The next level to watch is $4.25. If PRKR is able to cross it with volumes, then the movement will become much smoother. The main trigger for the recent move from $0.80 in March 2012 to the current levels (five times in one year) has been the expectations from the lawsuit against Qualcomm (QCOM). The more recent trigger was the rejection of Qualcomm's motion to drive out Parkervision's claims of indirect infringements in the patent violation lawsuit. This increased the potential of the awards (damages & royalties) tremendously. The volumes have been in excess of 1 million shares and the probability of a second breakout is reasonably good. This has more to do with the anticipation of positive outcome of the trial starting in October this year. Technically, the stock remains strong as it is above the 200 DMA ($2.68) and 50 DMA ($3.76). The 50 DMA should provide support in case there is any correction. Of course, if there is any negative news flow on the lawsuit, then the fortunes can change pretty quickly. The small companies taking on big companies has inspired many stories. Most of the tech giants are now involved in patent infringement lawsuits with smaller companies and patent monetization is a business model now. Spherix Inc. (SPEX), which is into research of drugs for diabetes and other ailments, recently sold its division (Spherix Consulting) to concentrate on the research. Spherix is keen on focusing on building an IPR portfolio which will offer more value to the investors. Parkervision will remain active till the hearing of the lawsuit, and more so after that. The investors have already been rewarded as the stock has moved from $0.8 to $4 in less than one year. Importantly, the momentum has just started to build up again, and a lot of the potential is yet to be tapped. Still, since the fate is dependent on the lawsuit, caution should be exercised at all times.